Mitral Stenosis
Mitral Stenosis, Native
Pathophysiology
- Leads to blood flow obstruction between left atrium and the LV
- Causes backflow from the LA, leading to elevated left atrial and pulmonary vascular pressures
- Progressive obstruction can lead to LA enlargement or atrial fibrillation
Pathology
- Rheumatic Fever from GAS is the MCC of mitral stenosis
- History of Rheumatic Heart Disease > Mitral annular calcification, SLE, RA, Radiation, Mucopolysaccharidosis, Carcinoid Syndrome, Myxoma, Amyl Nitrite, Endocarditis
- Antibodies cross-react with cardiac tissue
- Typically occurs in childhood but can happen at any age
- May be a latent period until symptoms occur (4th/5th decade)
Symptoms
- Typically begin w/MV area <1.5cm
- Gradual and progressive worsening dyspnea on exertion, orthopnea, PND
- Pulmonary edema ± right sided HF (LE Edema)
- Sometimes causes secondary pulmonary hypertension
Exam
- Eventually causes backflow into the LA, leading to elevated left atrial and pulmonary vascular pressures ± pulmonary vascular congestion
- Left Atrial Enlargement ensues
- Voice hoarseness or cough for Recurrent Laryngeal nerve compression (Ortner Syndrome)
- Mitral Facies (pink-purple patches on cheeks)
- Thickened pericardial stripe and splayed atriotrial on CXR
- Indicates left atrial enlargement or cancer
Murmur
- Low S1, Opening Snap after S2 best heard at the apex
- Followed by low-pitched mid-diastolic rumble with presystolic accentuation
- Tensing of the chordae tendinae and stenotic leaflets
- S1 is accentuated and can have a snapping quality
- Loud P2 if pulmonary hypertension develops
Diagnosis
- CXR: Displacement of the left main bronchus posteriorly or increased severity
- 70% of these patients develop Atrial Fibrillation due to LA dilation
- ECG: Systemic thromboemboli, stroke
- EKG: Partial/complete RBBB, right axis deviation, RVH Atrial enlargement, RV strain pattern
- Echocardiography: Pulmonary hypertension, dilated RV, tricuspid regurgitation
Treatment
- Diuretics for volume overload (loop diuretics)
- Beta-blockers or CCBs to slow ventricular rate and improve diastolic filling
- Anticoagulation if Atrial Fibrillation develops (warfarin preferred over DOAC in mechanical prostheses)
- Mechanical valve: Warfarin target INR 2.5-3.5
- Bioprosthetic valve: Warfarin target INR 2-3 for 3 months, then aspirin if no AF
- Percutaneous Mitral Balloon Valvotomy (PMBV) for symptomatic patients with suitable anatomy
- Mitral Valve Replacement if PMBV not feasible or failed